Delek US Holdings, Inc. (NYSE:DK - Get Free Report) has been assigned an average recommendation of "Reduce" from the fourteen research firms that are presently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $25.5385.
A number of equities research analysts recently weighed in on DK shares. Citigroup reissued a "neutral" rating and set a $30.00 price target (up from $15.00) on shares of Delek US in a research note on Wednesday, July 16th. Scotiabank reissued a "sector perform" rating and set a $20.00 price target (up from $14.00) on shares of Delek US in a research note on Friday, July 11th. Cowen reissued a "sell" rating on shares of Delek US in a research note on Friday, August 8th. TD Cowen dropped their price target on shares of Delek US from $18.00 to $15.00 and set a "sell" rating for the company in a research note on Friday, August 8th. Finally, Bank of America boosted their price target on shares of Delek US from $14.00 to $24.00 and gave the stock an "underperform" rating in a research note on Wednesday, September 3rd.
View Our Latest Report on DK
Delek US Price Performance
Shares of NYSE DK traded up $0.90 during trading on Friday, reaching $32.06. The company had a trading volume of 1,782,234 shares, compared to its average volume of 2,475,940. Delek US has a 52 week low of $11.02 and a 52 week high of $32.61. The stock has a market cap of $1.93 billion, a PE ratio of -2.61 and a beta of 1.09. The company has a debt-to-equity ratio of 10.48, a quick ratio of 0.50 and a current ratio of 0.80. The business's 50 day moving average price is $25.44 and its 200-day moving average price is $19.95.
Delek US (NYSE:DK - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The oil and gas company reported ($0.56) earnings per share for the quarter, topping analysts' consensus estimates of ($0.92) by $0.36. The business had revenue of $2.76 billion during the quarter, compared to the consensus estimate of $2.68 billion. Delek US had a negative net margin of 7.11% and a negative return on equity of 79.27%. Delek US's revenue for the quarter was down 16.4% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.92) earnings per share. Analysts expect that Delek US will post -5.5 earnings per share for the current year.
Delek US Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, August 18th. Shareholders of record on Monday, August 11th were paid a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend was Monday, August 11th. Delek US's dividend payout ratio is presently -8.30%.
Insider Buying and Selling
In other Delek US news, CFO Robert G. Wright sold 7,135 shares of the company's stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $29.24, for a total value of $208,627.40. Following the completion of the sale, the chief financial officer owned 48,294 shares of the company's stock, valued at approximately $1,412,116.56. This represents a 12.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.80% of the company's stock.
Institutional Investors Weigh In On Delek US
Several large investors have recently bought and sold shares of DK. CWM LLC increased its stake in Delek US by 100.9% in the first quarter. CWM LLC now owns 2,318 shares of the oil and gas company's stock valued at $35,000 after purchasing an additional 1,164 shares in the last quarter. AlphaQuest LLC boosted its holdings in shares of Delek US by 7,331.8% in the second quarter. AlphaQuest LLC now owns 1,635 shares of the oil and gas company's stock valued at $35,000 after buying an additional 1,613 shares during the period. Creative Financial Designs Inc. ADV acquired a new position in shares of Delek US in the first quarter valued at approximately $47,000. GAMMA Investing LLC boosted its holdings in shares of Delek US by 907.0% in the first quarter. GAMMA Investing LLC now owns 4,159 shares of the oil and gas company's stock valued at $63,000 after buying an additional 3,746 shares during the period. Finally, State of Wyoming acquired a new position in shares of Delek US in the first quarter valued at approximately $95,000. Institutional investors own 97.01% of the company's stock.
Delek US Company Profile
(
Get Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Further Reading

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.